Related Experiment Video
Updated: Aug 11, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
[Safety of oral anticoagulation in aged patients with heart diseases]
M C García Garay1, F Marín Ortuño, V Roldán Schilling
1Servicio de Hematología, Hospital General Universitario de Alicante.
Insights
Elderly patients on acenocoumarol anticoagulation showed a low rate of severe bleeding complications. Advanced age was not a contraindication for oral anticoagulant therapy in this study group.
Area of Science:
- Cardiology
- Geriatrics
- Pharmacology
Background:
- Anticoagulation therapy in elderly patients raises concerns about increased hemorrhagic risk.
- Hemorrhagic complications in patients over 70 receiving acenocoumarol for heart disease were investigated.
Purpose of the Study:
- To assess the safety and efficacy of acenocoumarol anticoagulation in elderly patients.
- To determine the incidence of hemorrhagic complications in this demographic.
Main Methods:
- A cohort of 72 patients (mean age 73 years) on acenocoumarol therapy for one year was monitored.
- International Normalized Ratio (INR) was measured bi-weekly, with therapeutic range defined as 2.0-4.5.
Main Results:
- 19 patients had elevated INR (>4.5) once, and 11 had elevated INR on multiple occasions.
- 16 patients experienced hemorrhagic complications; 5 required hospitalization but no transfusions.
- No cases of cerebral hemorrhage or peripheral embolism were reported.
Conclusions:
- The majority of elderly patients maintained therapeutic INR levels during acenocoumarol treatment.
- Severe hemorrhagic complications were infrequent, suggesting good safety profile.
- Advanced age did not appear to be a significant risk factor for adverse outcomes with oral anticoagulation.
Background:
Anticoagulation therapy in the elderly poses some doubts on the possible increase in hemorrhagic risk. The hemorrhagic complications in a population of patients over 70 years of age anticoagulated with acenocoumarol by heart disease were studied.
Materials And Methods:
A study was made of seventy-two patients (43 females and 29 males; mean age: 73 years) anticoagulated for one year and controlled on an outpatient basis by means of INR (international normalized ratio) measurement with a maximal interval of four weeks. INR values above 4.5 or below 2.0 were considered out of range.
Results:
Nineteen patients had an INR above the recommended value on one occasion and eleven patients on two or more occasions. Sixteen patients had hemorrhagic complications, five were admitted on account of hemorrhages although none of them required transfusional therapy. No cases of brain hemorrhage or peripheral embolism occurred.
Conclusions:
Most anticoagulated elderly patients were within their therapeutic range. The percentage of severe hemorrhagic complications was low. Advanced age had did not prove to be a factor against therapy with oral anticoagulants.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacodynamics in Geriatric Patients: Effects of Age

